HC Wainwright&Co.:重申Palatin Techs(PTN.US)评级,由买入调整至买入评级,目标价由17.00美元调整至17.00美元。palatin technologies(PTN.US)公司简介:Palatin Technologies Inc是一家生物制药公司,开发基于调节黑色素皮质素受体系统活性的分子的首创药物。其产品候选药物是针对特定受体的治疗药物,旨在治疗具有显著未...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.